Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,077 | 34,814 | 21,134 | 28,224 | 54,123 |
| Marketable Securities | 708,769 | 388,784 | 214,214 | 224,473 | 224,264 |
| Receivables | 2,671 | 2,628 | 252 | 118 | 1,314 |
| TOTAL | $835,324 | $431,693 | $245,933 | $264,820 | $289,597 |
| Non-Current Assets | |||||
| PPE Net | 4,061 | 4,060 | 4,162 | 3,938 | 3,995 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 27,190 |
| Other Non-Current Assets | 2,272 | 2,684 | 2,971 | 3,363 | 3,737 |
| TOTAL | $33,523 | $33,934 | $34,323 | $34,491 | $34,922 |
| Total Assets | $868,847 | $465,627 | $280,256 | $299,311 | $324,519 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 4,232 | 978 | N/A |
| Accounts payable and accrued liabilities | 3,234 | 3,494 | 3,586 | 881 | 3,374 |
| Accrued Expenses | 17,536 | 22,029 | 18,471 | 12,257 | 9,374 |
| Other current liabilities | 3,877 | 3,988 | N/A | N/A | 978 |
| TOTAL | $26,291 | $31,125 | $27,836 | $15,646 | $15,219 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,943 | 5,331 | 5,702 | 6,128 | 6,560 |
| TOTAL | $3,943 | $5,331 | $5,702 | $6,128 | $6,560 |
| Total Liabilities | $30,234 | $36,456 | $33,538 | $21,774 | $21,779 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,911 | 55,901 | 47,264 | 47,261 | 47,252 |
| Common Shares | 66 | 56 | 47 | 47 | 47 |
| Retained earnings | -1,430,169 | -1,397,361 | -1,354,055 | -1,315,795 | -1,285,293 |
| Other shareholders' equity | 2,244 | 3,308 | 2,135 | 2,072 | 2,123 |
| TOTAL | $838,613 | $429,171 | $246,718 | $277,537 | $302,740 |
| Total Liabilities And Equity | $868,847 | $465,627 | $280,256 | $299,311 | $324,519 |